ANXA5 and endometriosis: In the same study, menstrual plasma levels of 3 biomarkers (VEGF, Annexin V, and CA-125) allowed the diagnosis of endometriosis (stages I-IV, both with and without US evidence) with 85% sensitivity and 75% specificity [11].